Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Immune reconstitution after HLA-HSCT

Leonido Luznik • 26 Oct 2019
COSTEM 2019
General

Leo Luznik, MD, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MA, discusses immune reconstitution after T-cell replete HLA-haploidentical transplantation (HLA-HSCT) at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Leonido Luznik

Prevention strategies for acute and chronic GVHD in patients who have undergone transplantation
1:18
Prevention strategies for acute and chronic GVHD in patients who have undergone transplantation
Leonido Luznik • 21 Oct 2023
The role of PTCy/MMF/CNI as the standard of care for GvHD prophylaxis in the MUD setting
2:03
The role of PTCy/MMF/CNI as the standard of care for GvHD prophylaxis in the MUD setting
Leonido Luznik • 21 Oct 2023
Promising strategies to prevent GvHD in high-risk patients
1:13
Promising strategies to prevent GvHD in high-risk patients
Leonido Luznik • 21 Oct 2023
Donor type and source of choice
1:55
Donor type and source of choice
Leonido Luznik • 26 Oct 2019

Related Videos

Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026
Current role of AI in hematology/oncology: separating the hype from reality
2:54
Current role of AI in hematology/oncology: separating the hype from reality
Adrián Mosquera Orgueira • 24 Sep 2026
Addressing the risk of over-reliance on AI in clinical decision-making
2:25
Addressing the risk of over-reliance on AI in clinical decision-making
Adrián Mosquera Orgueira • 24 Sep 2026
Telomere dynamics in normal and pathological aging
12:41
Telomere dynamics in normal and pathological aging
Coleman Lindsley • 18 Sep 2026
The content of VJHemOnc is intended for healthcare professionals